Research Projects & Grants

For Profit Organization

  • GORE® CARDIOFORM Septal Occluder and Antiplatelet medical management for reduction of recurrent stroke in patients with Patent Foremen Ovale (PFO): The REDUCE post approval study, Role: PI, W.L. Gore & Associates, Inc., (06/2024 - 06/2025) Status: Approved
  • A Prospective, Multi-Center, Randomized, Controlled, Single Blind Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class Ill Heart Failure Patients (PROACTIVE- HF Trial), Role: Investigator, Endotronix, Inc., (01/2025 - 01/2026) Status: Approved
  • ARTEMIS D5130R00030: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study, Role: Investigator, AstraZeneca (UK HQ), (07/2017 - 07/2018) Status: Completed

Internal

  • HUD: PK Papyrus Covered Coronary Stent System, Role: Investigator, LLU Dept. of Medicine, (05/2024 - 05/2025) Status: Approved
  • National cardiogenic shock initiative, Role: Investigator, LLU Dept. of Cardiology, (07/2020 - 07/2021) Status: Completed
  • A Retrospective Analysis and Review of Patients Undergoing Impella, a Temporary Left Ventricular Support Device, Implantation for Complex Coronary Intervention or Cardiogenic Shock, Role: Investigator, LLU Dept. of Medicine, (04/2020) Status: Approved

Non-Profit Organization

  • Cardiovascular inflammation reduction trial (CIRT): a randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose Methotrexate(LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome, Role: Investigator, Brigham & Women's Hospital, (08/2017 - 08/2018) Status: Completed